Hualan Biological Engineering Inc. (SHE:002007)
China
· Delayed Price · Currency is CNY 16.38
-0.03 (-0.18%)
Feb 21, 2025, 3:04 PM CST
SHE:002007 Revenue
Hualan Biological Engineering had revenue of 1.84B CNY in the quarter ending September 30, 2024, a decrease of -21.04%. This brings the company's revenue in the last twelve months to 4.92B, up 1.90% year-over-year. In the year 2023, Hualan Biological Engineering had annual revenue of 5.34B with 18.26% growth.
Revenue (ttm)
4.92B
Revenue Growth
+1.90%
P/S Ratio
6.08
Revenue / Employee
1.33M
Employees
3,709
Market Cap
29.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
| Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
| Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
| Dec 31, 2020 | 5.02B | 1.32B | 35.76% |
| Dec 31, 2019 | 3.70B | 483.04M | 15.02% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |